US Approves First Pill With Digital Tracking Device
Sumaira FH Published November 14, 2017 | 09:05 PM
US regulators have approved the first pill that contains a digital tracking sensor to alert doctors and caregivers as to whether a patient is taking a medication as scheduled
Washington, (APP - UrduPoint / Pakistan Point News - 14th Nov, 2017 ) :US regulators have approved the first pill that contains a digital tracking sensor to alert doctors and caregivers as to whether a patient is taking a medication as scheduled.
The pill, called Abilify MyCite (aripiprazole tablets with sensor), is designed for patients with schizophrenia, bipolar disorder and depression, according to the US food and Drug Administration.
A patient ingests the pill, and a sensor inside the pill activates when it reaches the stomach fluids, sending a message to a wearable patch. This patch then transmits the information to a mobile app, so that a doctor and up to four caregivers, friends or family members can see the information through a web-based portal.
"Being able to track ingestion of medications prescribed for mental illness may be useful for some patients," said Mitchell Mathis, director of the division of psychiatry products in the FDA's Center for Drug Evaluation and Research, in a statement Monday afternoon.
"The FDA supports the development and use of new technology in prescription drugs and is committed to working with companies to understand how technology might benefit patients and prescribers." Although the sensor can alert caregivers, the makers of Abilify, Japan-based Otsuka Pharmaceutical, said it is unclear whether the tracking device will actually help improve patients' ability to take their medication daily as prescribed.
The FDA approved Abilify in 2002 to treat schizophrenia, which affects about one percent of the US population. The ingestible sensor used in Abilify MyCite was first allowed on the market by the FDA in 2012.
The sensor technology and patch are made by Proteus Digital Health, and are approved for use with existing medications in the United States and Europe. But until now, the FDA had not approved a sensor-pill combination.
Related Topics
Recent Stories
Currency Rate In Pakistan - Dollar, Euro, Pound, Riyal Rates On 26 April 2024
Today Gold Rate in Pakistan 26 April 2024
ICC Womens T20 World Cup Qualifier, Match 2: Ireland Women open with Comfortable ..
Robinson, bowlers help New Zealand go 2-1 up against Pakistan
Shahzeb Chachar to hold khuli kachehri on April 26
Heatwave amid Israel's aggression in Gaza brings new misery, disease risk
Tourism must change, mayor says as Venice launches entry fee
Court adjourns Judicial Complex attack case till May 17
Nasreen Noori’s book ‘Popatan Jahra Khwab’ launched
Wafaqi Mohtasib inspection team visits Excise and taxation office
AJLAC announces 5th Conference titled ‘People’s Mandate: Safeguarding Civil ..
Pak-US officials engage to enhance trade, investment ties
More Stories From World
-
Nuggets push Lakers to brink as Embiid's 50 points lead Sixers over Knicks
7 minutes ago -
Man City in title groove as Arsenal face Spurs test
7 minutes ago -
Philippine settlement submerged by dam reappears due to drought
7 minutes ago -
ByteDance says 'no plans' to sell TikTok after US ban law
46 minutes ago -
Oil: 'Mother of corruption' in Venezuela
47 minutes ago -
ECO General Secretary urges member nations to embrace cultural wealth
47 minutes ago
-
China warns Blinken over deteriorating ties in talks
57 minutes ago -
Famine-threatened Sudan's 'race against time' to plant crops
1 hour ago -
Microsoft, Google earnings shine as AI drives revenue
1 hour ago -
Man City crush Brighton to close gap on Arsenal in title race
1 hour ago -
Atletico face Bilbao challenge in Champions League race
2 hours ago -
Man City in title groove as Arsenal face Spurs test
2 hours ago